March 2, 2020

Gilead Sciences buying Forty Seven for $4.9 billion

Gilead Sciences is buying the cancer treatment company Forty Seven in a deal valued at approximately $4.9 billion.

Gilead, based in Foster City, California, will pay $95.50 for each Forty Seven Inc. share.

Gilead said Monday that the transaction will strengthen its immuno-oncology research and development portfolio with the addition of of Forty Seven Inc.'s investigational lead product candidate, magrolimab, which is in for the treatment of several cancers.

Forty Seven's stock soared more than 60% before the market open. Gilead rose 1.2%.

The deal is targeted to close in the .

© 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Citation: Gilead Sciences buying Forty Seven for $4.9 billion (2020, March 2) retrieved 24 May 2024 from https://medicalxpress.com/news/2020-03-gilead-sciences-forty-billion.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Gilead faces lawsuit over hepatitis C drug pricing
 shares

Feedback to editors
Integration of pharmacies with physician practices has little impact on cancer drug expenditures, study finds

2 minutes ago
Study finds heat pain perception decreases with age

3 minutes ago
Colon cancers are rising among the young: New study outlines the warning signs

13 minutes ago
New mechanism of immune evasion in squamous cell carcinoma offers potential for improved treatment

1 hour ago
Scientists show that serotonin activates brain areas influencing behavior and motivation

1 hour ago
Researchers develop new light-controlled 'off switch' for brain cells

1 hour ago
New global targets proposed to reduce AMR-linked deaths and improve access to essential antibiotics

1 hour ago
Harnessing the power of viruses to kill cancers

1 hour ago
Scientists leverage machine learning to decode gene regulation in the developing human brain

1 hour ago
Study connects genetic risk for autism to changes observed in the brain

2 hours ago
Load comments (0)